Witness· PFM Health Sciences
Brian Grossman
PFM Health Sciences investment manager involved in the firm's Theranos diligence and investments.
AppearedFederal Criminal Trial
1,759 lines·4 appearances·12 mentions
About
Testifying for the government, Grossman described PFM's Theranos diligence, investment assumptions, and financial modeling. Cross-examination emphasized PFM's sophistication and known risks, while he explained that restricted access and incomplete technical information left the firm relying in part on Theranos representations.
Trial Record (16)
FederalFederal Criminal TrialAug 31, 2021 – Jan 3, 2022
Testimony (4)
Direct
Brian Grossman — Direct
Day 33CrossBrian Grossman — Cross
Day 33CrossBrian Grossman — Cross
Day 34RedirectBrian Grossman — Redirect
Day 34Mentioned (12)
Opening
Opening Statement by the Defense — Resumed
Day 4OpeningOpening Statement by the Prosecution
Day 4DirectAdam Rosendorff — Direct
Day 11CrossWade Miquelon — Cross
Day 18CrossSo-Han Spivey — Cross
Day 33ProceduralSealed In-Camera Proceeding Regarding Prior Sealed Matter
Day 33ProceduralHearing on Admission of Sunny Balwani’s Prior Testimony
Day 39ProceduralHearing on Defense Motion 1163 and Balwani Deposition Excerpts
Day 40ProceduralContinued Hearing on Defense Motion 1163
Day 40CrossElizabeth A. Holmes — Cross
Day 42ClosingClosing Argument by the Defense — Continued
Day 47RebuttalRebuttal Closing Argument by the Prosecution
Day 47